PCN13 Quality-of-Life (QOL) Results from the Phase 3 Rainbow-ASIA Study of Ramucirumab PLUS paclitaxel (RAM/PTX) Versus Placebo PLUS paclitaxel (PBO/PTX) in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (AGC)
Abstract
Authors
R. Xu L. Shen Y. Qin S. Qin X. Yin B. Liu S. Tanasanvimon C. Zhou W. Zhang L. Zhou